REG - Ergomed plc - Cancellation of admission to trading of shares

ErgomedAnnouncement

14/11/2023 07:30

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231114:nRSN2856Ta&default-theme=true

RNS Number : 2856T  Ergomed plc  14 November 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

 

 

For immediate release

 

14 November 2023

 

Ergomed plc

 

 

Cancellation of admission to trading of Ergomed Shares

 

 

Further to the announcement on 13 November 2023 that the Scheme for the
acquisition of the entire issued and to be issued ordinary share capital of
Ergomed plc ("Ergomed" or the "Company") by Eden AcquisitionCo Limited has now
become Effective in accordance with its terms, Ergomed confirms that AIM has
cancelled the admission to trading of Ergomed Shares on AIM with effect from
7.00 a.m. today, 14 November 2023.

Defined terms used but not defined in this announcement have the meanings set
out in the Scheme Document dated 22 September 2023.  All references to times
in this announcement are to London time.

Enquiries:

Ergomed
 
                         +44 (0) 1483 307 920

Miroslav Reljanović (Executive
Chairman)

Jonathan Curtain (Chief Financial Officer)

Keith Byrne (Senior Vice President, Capital Markets and
Strategy)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCDZMMMVFZGFZM